Vanguard FTSE 100 UCITS ETF

Issuer: Vanguard
Asset Class: Equity
TER: 9bps
Trading Currency: GBP
Pays Income: False
Listing Date: 23 May 2012
Ticker: VUKE
ISIN: IE00B810Q511
This fund offers a targeted and efficient way to invest in the UK's largest public companies. By tracking the FTSE 100 index, it provides exposure to the 100 biggest firms listed on the London Stock Exchange, representing a significant portion of the total UK market capitalization. This benchmark is composed of well-established, blue-chip companies, many of which are multinational corporations with substantial global operations. Key sector exposures typically include financials, consumer staples, energy, industrials, and healthcare, offering a diversified snapshot of the UK's corporate landscape. As a core holding, it allows investors to participate in the performance of the British economy's leading enterprises through a single, low-cost investment.

The strategy employs a physical replication method, meaning it directly purchases and holds the shares of the companies within the index, closely mirroring its composition and performance. This approach provides transparency and avoids the counterparty risk associated with synthetic, swap-based products. This particular share class is distributing, meaning it pays out dividends received from the underlying companies to investors on a regular basis, typically quarterly. This feature can be attractive for those seeking a regular income stream in addition to the potential for capital appreciation. The fund's low expense ratio makes it a cost-effective vehicle for gaining foundational exposure to UK large-cap equities.

An investment in this product carries risks inherent to equity markets, including market volatility and the potential for capital loss. As it concentrates on a single country, the fund is particularly susceptible to economic, political, and regulatory developments specific to the United Kingdom. The performance of the FTSE 100 is also influenced by global economic trends due to the international nature of its constituents. Therefore, while it serves as an excellent tool for UK market exposure, investors should consider it as part of a globally diversified portfolio to mitigate concentration risk and enhance long-term risk-adjusted returns.

Other Exchange Listings